Chilton Capital Management Raised By $8.29 Million Its Citigroup (C) Position; Paratek Pharmaceuticals, Inc. (PRTK) Covered By 9 Bulls

February 19, 2018 - By Linda Rogers

Among 10 analysts covering Paratek Pharmaceuticals (NASDAQ:PRTK), 9 have Buy rating, 0 Sell and 1 Hold. Therefore 90% are positive. Paratek Pharmaceuticals had 24 analyst reports since July 23, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Monday, June 5 by Cantor Fitzgerald. The stock of Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) earned “Buy” rating by Gabelli on Thursday, July 23. On Friday, May 13 the stock rating was initiated by Robert W. Baird with “Outperform”. The rating was reinitiated by Leerink Swann on Thursday, October 27 with “Outperform”. The rating was upgraded by Zacks on Tuesday, September 22 to “Hold”. As per Friday, June 17, the company rating was maintained by H.C. Wainwright. The rating was maintained by Cantor Fitzgerald with “Buy” on Thursday, June 29. The rating was maintained by Ladenburg Thalmann on Friday, June 17 with “Buy”. The firm has “Buy” rating by H.C. Wainwright given on Tuesday, July 18. The firm has “Hold” rating by Zacks given on Saturday, August 8. See Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) latest ratings:

08/11/2017 Broker: Cantor Fitzgerald Rating: Buy New Target: $50.0 Maintain
24/10/2017 Broker: Robert W. Baird Rating: Buy New Target: $40.0 Maintain
24/10/2017 Broker: Guggenheim Rating: Buy New Target: $44 Initiates Coverage On
21/09/2017 Broker: Robert W. Baird Rating: Buy New Target: $40.0 Maintain
23/08/2017 Broker: Cantor Fitzgerald Rating: Buy Maintain

Chilton Capital Management Llc increased Citigroup Inc (C) stake by 3284.62% reported in 2017Q3 SEC filing. Chilton Capital Management Llc acquired 115,093 shares as Citigroup Inc (C)’s stock rose 1.55%. The Chilton Capital Management Llc holds 118,597 shares with $8.63 million value, up from 3,504 last quarter. Citigroup Inc now has $197.41 billion valuation. The stock decreased 0.34% or $0.26 during the last trading session, reaching $76.82. About 11.64M shares traded. Citigroup Inc. (NYSE:C) has risen 35.60% since February 19, 2017 and is uptrending. It has outperformed by 18.90% the S&P500.

Chilton Capital Management Llc decreased Johnson & Johnson (NYSE:JNJ) stake by 4,386 shares to 81,820 valued at $10.64M in 2017Q3. It also reduced Visa Inc (NYSE:V) stake by 6,867 shares and now owns 117,472 shares. American Express Co (NYSE:AXP) was reduced too.

Investors sentiment increased to 1.35 in Q3 2017. Its up 0.25, from 1.1 in 2017Q2. It is positive, as 56 investors sold C shares while 400 reduced holdings. 125 funds opened positions while 492 raised stakes. 2.04 billion shares or 0.42% more from 2.03 billion shares in 2017Q2 were reported. Cibc Ww Markets reported 298,440 shares or 0.1% of all its holdings. Moreover, Paragon Mngmt has 0.2% invested in Citigroup Inc. (NYSE:C). Condor Capital invested in 0.47% or 32,182 shares. The Pennsylvania-based Twin Capital has invested 1.39% in Citigroup Inc. (NYSE:C). Greenleaf Trust accumulated 134,446 shares or 0.21% of the stock. Huntington Natl Bank reported 38,642 shares. Pl Advsrs Limited Co stated it has 1.78% of its portfolio in Citigroup Inc. (NYSE:C). Bluefin Trading Limited Co invested in 0.18% or 21,400 shares. Bailard holds 6,083 shares or 0.03% of its portfolio. Emerald Advisers Pa stated it has 0.02% of its portfolio in Citigroup Inc. (NYSE:C). Shelton holds 43,156 shares or 0.24% of its portfolio. Arrowstreet Cap Limited Partnership, Massachusetts-based fund reported 3.09M shares. Rothschild Asset reported 0.18% in Citigroup Inc. (NYSE:C). Retirement System Of Alabama invested in 0.87% or 2.28M shares. Connor Clark Lunn Inv Mgmt Ltd invested in 0.15% or 347,975 shares.

Among 40 analysts covering Citigroup Inc. (NYSE:C), 19 have Buy rating, 3 Sell and 18 Hold. Therefore 48% are positive. Citigroup Inc. had 116 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Buy” rating by Guggenheim given on Friday, August 28. The rating was maintained by Deutsche Bank on Tuesday, January 26 with “Hold”. Deutsche Bank maintained it with “Hold” rating and $60 target in Wednesday, August 12 report. The stock of Citigroup Inc. (NYSE:C) has “Buy” rating given on Monday, October 9 by Credit Suisse. The stock has “Outperform” rating by Oppenheimer on Tuesday, October 6. The rating was maintained by Keefe Bruyette & Woods on Wednesday, June 7 with “Buy”. UBS reinitiated Citigroup Inc. (NYSE:C) rating on Wednesday, January 11. UBS has “Sell” rating and $58 target. Nomura maintained it with “Buy” rating and $81 target in Friday, October 13 report. The company was maintained on Friday, October 6 by BMO Capital Markets. Credit Suisse upgraded the stock to “Outperform” rating in Monday, September 28 report.

The stock increased 0.18% or $0.025 during the last trading session, reaching $13.975. About 424,128 shares traded. Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) has risen 62.03% since February 19, 2017 and is uptrending. It has outperformed by 45.33% the S&P500.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts